Cancer center support grant

癌症中心补助金

• 批准号: 10372714
• 负责人: RAPHAEL E. POLLOCK
• 金额: $ 1.08万
• 依托单位: OHIO STATE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 1997
• 资助国家: 美国
• 起止时间: 1997-09-12 至 2025-11-30
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10372714
• 关键词: Address; African American; Appalachian Region; Asians; Awareness; Basic Science; Breast; Cancer Center; Cancer Center Support Grant; Cancer Hospital; Caring; Catchment Area; Caucasians; Clinical Research; Clinical Trials; Colorectal; Communities; Community Health; Community Networks; Community Outreach; Comprehensive Cancer Center; Development; Diagnosis; Education and Outreach; Endometrial; Ensure; Foundations; Goals; Health Educators; Hispanics; Human Papilloma Virus Vaccination; Human Papilloma Virus Vaccine; Human Papillomavirus; Individual; Knowledge; Latino; Lead; Lesbian Gay Bisexual Transgender Queer; Longevity; Low income; Lung; Malignant Neoplasms; Malignant neoplasm of cervix uteri; Mission; Modality; Morbidity - disease rate; Multicultural Education; Obesity; Ohio; Policies; Population; Population Heterogeneity; Population Research; Prostate; Public Health; Recording of previous events; Refugees; Research; Research Institute; Research Personnel; Rural; Scanning; Screening for cancer; Thyroid Gland; Tobacco use; Translational Research; Underserved Population; Universities; University resources; Vaccination; Vision; Work; cancer care; care seeking; clinical trial implementation; community based participatory research; community engagement; disparity elimination; ethnic diversity; ethnic minority population; health disparity; leukemia; minority communities; mortality; outreach; prevent; programs; racial and ethnic; rural counties; screening; underserved community; uptake; urban underserved; vaccine acceptance

Project Summary The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) has been a NCI designated CCC since 1976. The OSUCCC mission remains to reduce cancer morbidity and mortality through continued basic, translational, population and clinical research. Eliminating disparities across the continuum of cancer care, with the inclusion of a diverse population in research, is vital to the development of new modalities to prevent, diagnose, and treat cancer. The OSUCCC is committed to providing the best care across the cancer continuum to all individuals who seek care at our facilities, which includes participation in research. One way to ensure that the population within the OSUCC-James catchment area receives best possible care is through engaging the various communities and providing cancer awareness, especially an understanding of the importance of trial participation. We will focus the proposed supplement on implementing a Clinical Trials Initiative within our urban underserved African American, low income Caucasian, Hispanic/Latino, Asian, and refugee (Somali and Nepali) communities, and an HPV Vaccination Initiative in all of these populations, as well as in our Appalachian and rural counties. To accomplish the goals of this NON supplement and build upon previous outreach efforts aimed at eliminating health disparities, OSUCCC will utilize two community health educators (1.2 total FTE) to work in partnership with researchers and key NCI-sponsored academic, and community, and regional partners to enhance NCI’s ability to effectively reach underserved and minority communities through achieving the following specific aims: Aim 1: Increase awareness and knowledge about clinical trials and biospecimen research and facilitate participation in clinical trials among racially/ethnically diverse communities in urban Columbus communities through implementation of Clinical Trial (CT) & Biospecimen Studies Participation Initiative; and Aim 2: Increase awareness and knowledge of the HPV types that can lead to cancer and uptake of the HPV vaccine in the various underserved populations in our catchment area through implementation of the Human Papillomavirus (HPV) Outreach and Vaccination initiative.

项目摘要 俄亥俄州州立大学综合癌症中心-亚瑟G。詹姆斯癌症医院和 Richard J. Solove Research Institute（OSUCCC - James）自1976年以来一直是NCI指定的CCC。的 OSUCCC的使命仍然是通过持续的基础，转化， 人口和临床研究。 消除癌症护理连续性中的差异，纳入多元化人群 研究，是至关重要的新模式，以预防，诊断和治疗癌症的发展。OSUCCC是 致力于为所有在我们的设施寻求护理的癌症患者提供最好的护理， 包括参与研究。确保OSUCC-James内的人口 集水区得到最好的照顾是通过参与各种社区和提供癌症 意识，尤其是对参与审判重要性的理解。 我们会把拟议补充拨款的重点放在在市区推行临床试验计划， 服务不足的非裔美国人，低收入高加索人，西班牙裔/拉丁裔，亚洲人和难民（索马里和尼泊尔） 社区，并在所有这些人群中实施HPV疫苗接种计划，以及在我们的阿巴拉契亚和 农村县。 为了实现这一非国家行动方案补编的目标，并在以往外联工作的基础上， 为了消除健康差距，OSUCCC将利用两名社区健康教育工作者（1.2个全职工作人员）， 与研究人员和主要NCI赞助的学术，社区和区域合作伙伴建立伙伴关系， 通过实现以下目标，增强国家癌症研究所的能力，使其能够有效地接触到服务不足的社区和少数民族社区 具体目标： 目标1：提高对临床试验和生物标本研究的认识和知识， 参与哥伦布城市社区种族/族裔多样化社区的临床试验 通过实施临床试验（CT）和生物样本研究参与倡议;以及 目的2：提高对可导致癌症的HPV类型和HPV摄取的认识和知识 通过实施人类免疫接种计划， 乳头瘤病毒（HPV）推广和疫苗接种倡议。